AR037068A1 - Procedimiento para preparar compuestos de 10,11-metanodibenzosuberano y sales farmaceuticamente aceptables de los mismos; metodo para preparar compuestos intermediarios de aplicacion en dicho procedimiento;triclorhidratos cristalinos de (2r)-anti-5-{3-[4-(10,11-difluorometanodibenzo-5-il)piperacin-1 - Google Patents
Procedimiento para preparar compuestos de 10,11-metanodibenzosuberano y sales farmaceuticamente aceptables de los mismos; metodo para preparar compuestos intermediarios de aplicacion en dicho procedimiento;triclorhidratos cristalinos de (2r)-anti-5-{3-[4-(10,11-difluorometanodibenzo-5-il)piperacin-1Info
- Publication number
- AR037068A1 AR037068A1 ARP000102679A ARP000102679A AR037068A1 AR 037068 A1 AR037068 A1 AR 037068A1 AR P000102679 A ARP000102679 A AR P000102679A AR P000102679 A ARP000102679 A AR P000102679A AR 037068 A1 AR037068 A1 AR 037068A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- procedure
- compound
- compounds
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Catalysts (AREA)
Abstract
Se describe y reivindica un procedimiento para preparar derivados de 10,11-metanodibenzosuberano (opcionalmente sustituido). La presente también proporciona un intermedio de este procedimiento. Dicho procedimiento comprende la preparación de compuestos de fórmula (1),en la que A es -CH2-CH2-, -CH2-CHRa-CH2-, -CH2-CHRa-CH2-CH2-, y Ra es OH; R1 es H, F, Cl ó Br; R2 es H, F, Cl ó Br; y R3 es heteroarilo o fenilo, cada uno opcionalmente sustituido con F, Cl, Br, CF3, CN, NO2 ó OCHF2; o las sales farmacéuticamente aceptables del mismo, caracterizado porque comprende las etapas de: (a) hacer reaccionar un compuesto de fórmula (2) con una fuente de nucleófilos para formar un compuesto de fórmula (3); (b) hacer reaccionar un compuesto de fórmula (3) con pirazina para proporcionar un compuesto de fórmula (4); (c) reducir el compuesto de fórmula (4) para proporcionar un compuesto de fórmula (5); (d) hacer reaccionar un compuesto de fórmula (5) con: (i) un compuesto epoxídico de fórmula (6) en la que R3 es como se ha definido y n es el número entero 1 ó 2; ó (ii) un compuesto halo de fórmula (7): X1 - (CH2)m - O - R3, en la que R3 es como se ha definido anteriormente, X1 es halo y m es 2, 3 ó 4; y (e) formar opcionalmente una sal farmacéuticamente aceptable de un compuestos de fórmula (6) ó (7).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13728399P | 1999-06-03 | 1999-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR037068A1 true AR037068A1 (es) | 2004-10-20 |
Family
ID=22476642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102679A AR037068A1 (es) | 1999-06-03 | 2000-05-31 | Procedimiento para preparar compuestos de 10,11-metanodibenzosuberano y sales farmaceuticamente aceptables de los mismos; metodo para preparar compuestos intermediarios de aplicacion en dicho procedimiento;triclorhidratos cristalinos de (2r)-anti-5-{3-[4-(10,11-difluorometanodibenzo-5-il)piperacin-1 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6521755B1 (es) |
| EP (1) | EP1189887A2 (es) |
| JP (1) | JP2003501421A (es) |
| KR (1) | KR100692351B1 (es) |
| AR (1) | AR037068A1 (es) |
| AU (1) | AU5123300A (es) |
| BR (1) | BR0011559A (es) |
| CA (1) | CA2378735A1 (es) |
| CO (1) | CO5170530A1 (es) |
| EG (1) | EG24072A (es) |
| HU (1) | HUP0203421A3 (es) |
| IL (2) | IL146810A0 (es) |
| MX (1) | MXPA01012296A (es) |
| MY (1) | MY123517A (es) |
| PE (1) | PE20010216A1 (es) |
| SV (1) | SV2002000088A (es) |
| TW (1) | TWI267511B (es) |
| WO (1) | WO2000075121A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60014386T2 (de) * | 1999-06-03 | 2005-10-13 | Eli Lilly And Co., Indianapolis | Verfahren zur herstellung von 10,11methanodibenzosuberanderivaten |
| AU2001269708A1 (en) * | 2000-07-18 | 2002-01-30 | Eli Lilly And Company | Novel method of use of multidrug resistance modulators |
| JP2004527552A (ja) | 2001-04-25 | 2004-09-09 | イーライ・リリー・アンド・カンパニー | （２ｒ）−アンチ−５−｛３−［４−（１０，１１−ジフルオロメタノジベンゾスベラ−５−イル）ピペラジン−１−イル］−２−ヒドロキシプロポキシ｝キノリンの新規な塩および結晶形態 |
| US11930815B1 (en) | 2023-08-29 | 2024-03-19 | King Faisal University | 3,3′-(piperazine-1,4-diyl)bis(1-(naphthalen-2-yloxy)propan-2-ol) as insecticidal agent |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| JPS6147466A (ja) * | 1984-08-10 | 1986-03-07 | Dainippon Pharmaceut Co Ltd | アミン誘導体 |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| US5643909A (en) | 1993-04-19 | 1997-07-01 | Syntex (U.S.A.) Inc. | 10,11-Methanodibenzosuberane derivatives |
-
2000
- 2000-05-22 TW TW089109803A patent/TWI267511B/zh not_active IP Right Cessation
- 2000-05-23 MY MYPI20002248A patent/MY123517A/en unknown
- 2000-05-26 KR KR1020017015505A patent/KR100692351B1/ko not_active Expired - Fee Related
- 2000-05-26 BR BR0011559-2A patent/BR0011559A/pt not_active Application Discontinuation
- 2000-05-26 HU HU0203421A patent/HUP0203421A3/hu unknown
- 2000-05-26 SV SV2000000088A patent/SV2002000088A/es unknown
- 2000-05-26 IL IL14681000A patent/IL146810A0/xx active IP Right Grant
- 2000-05-26 US US09/980,847 patent/US6521755B1/en not_active Expired - Fee Related
- 2000-05-26 EP EP00935832A patent/EP1189887A2/en not_active Withdrawn
- 2000-05-26 AU AU51233/00A patent/AU5123300A/en not_active Abandoned
- 2000-05-26 CA CA002378735A patent/CA2378735A1/en not_active Abandoned
- 2000-05-26 MX MXPA01012296A patent/MXPA01012296A/es unknown
- 2000-05-26 JP JP2001501602A patent/JP2003501421A/ja active Pending
- 2000-05-26 WO PCT/US2000/009826 patent/WO2000075121A2/en not_active Ceased
- 2000-05-27 EG EG20000680A patent/EG24072A/xx active
- 2000-05-29 CO CO00039595A patent/CO5170530A1/es not_active Application Discontinuation
- 2000-05-31 AR ARP000102679A patent/AR037068A1/es unknown
- 2000-06-01 PE PE2000000541A patent/PE20010216A1/es not_active Application Discontinuation
-
2001
- 2001-11-29 IL IL146810A patent/IL146810A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1189887A2 (en) | 2002-03-27 |
| PE20010216A1 (es) | 2001-02-27 |
| HUP0203421A2 (hu) | 2003-02-28 |
| TWI267511B (en) | 2006-12-01 |
| SV2002000088A (es) | 2002-01-23 |
| KR20020038587A (ko) | 2002-05-23 |
| AU5123300A (en) | 2000-12-28 |
| IL146810A (en) | 2007-06-03 |
| KR100692351B1 (ko) | 2007-03-09 |
| WO2000075121A2 (en) | 2000-12-14 |
| EG24072A (en) | 2008-05-11 |
| BR0011559A (pt) | 2002-02-26 |
| CA2378735A1 (en) | 2000-12-14 |
| MY123517A (en) | 2006-05-31 |
| HUP0203421A3 (en) | 2003-05-28 |
| JP2003501421A (ja) | 2003-01-14 |
| IL146810A0 (en) | 2002-07-25 |
| CO5170530A1 (es) | 2002-06-27 |
| WO2000075121A3 (en) | 2001-04-26 |
| US6521755B1 (en) | 2003-02-18 |
| MXPA01012296A (es) | 2002-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200300211A1 (ru) | Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств | |
| EA200400387A1 (ru) | Азабициклические замещённые конденсированные гетероарильные соединения для лечения заболеваний | |
| ATE361916T1 (de) | Pyrimidine verbindungen | |
| CY1107403T1 (el) | Μια μεθοδος δια την παρασκευη υπερινδοπριλης,των αναλογων ενωσεων αυτης και των αλατων αυτων με χρησιμοποιηση ενδιαμεσων ενωσεων 2,5-διοξο-οξαζολιδινης | |
| AR045557A1 (es) | Sintesis selectivas de pirimidinas sustituidas con cf3 | |
| RU2005105564A (ru) | Производные бензимидазола и их применение в качестве пролекарств ингибиторов протонного насоса | |
| EA200500690A1 (ru) | Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат | |
| AR074128A1 (es) | Derivados de 4-[2-(2-fluorofenoximetil)fenil] piperidina, composiciones farmaceuticas que los contienen, metodo de preparacion, compuestos intermediarios de dicho proceso y uso de los mismos para el tratamiento de dolores neuropaticos, mal de alzheimer y otras enfermedades relacionadas con el snc. | |
| EA200300927A1 (ru) | Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов | |
| RU2010147938A (ru) | Способ получения промежуточных соединений нафталин-2-ид-пиразол-3-она, используемых в синтезе ингибиторов сигма рецептора | |
| EA200800502A1 (ru) | Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения | |
| AR037068A1 (es) | Procedimiento para preparar compuestos de 10,11-metanodibenzosuberano y sales farmaceuticamente aceptables de los mismos; metodo para preparar compuestos intermediarios de aplicacion en dicho procedimiento;triclorhidratos cristalinos de (2r)-anti-5-{3-[4-(10,11-difluorometanodibenzo-5-il)piperacin-1 | |
| CO5590934A2 (es) | Procedimiento de preparacion de derivados de equinocandina | |
| AR034206A1 (es) | Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos | |
| JP2006523626A5 (es) | ||
| NO933010L (no) | 4-((2-benzotiazolyl)metylamino)alfa-((3,4-difluorfenoksy)metyl)-1-piperidinetanol | |
| AR045548A1 (es) | Derivados de imidazol | |
| DK1257552T3 (da) | Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose | |
| NO20000373L (no) | Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| CO5660263A2 (es) | Derivados de imidazol heteroaril sustituidos como antagonistas del receptor de glutamato | |
| DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
| EA200500683A1 (ru) | Новые соединения пирролидина и тиазолидина, способ их получения и фармацевтические композиции, которые их содержат | |
| EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие | |
| BRPI0707203C1 (pt) | compostos derivados de indoloquinoxalina úteis para o tratamento de infecções virais, método para preparar os compostos, e, composição farmacêutica | |
| NO20002315L (no) | Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |